Kolla Kristjansdottir, Ph.D.

Associate Professor
Downers Grove, IL

Home / Academics / Our Faculty / Kolla Kristjansdottir, Ph.D.


Dr. Kristjansdottir received her Ph.D. in Biochemistry from Duke University in Durham, North Carolina in 2005. She completed her Postdoctoral Fellowship at the The University of Chicago in 2011 and continued there as a Research Associate until 2012 studying alterations in phosphoproteomic signaling in several systems including the yeast cell cycle, tamoxifen resistance in breast cancer and the pediatric cancer, neuroblastoma . She joined Midwestern University in Downers Grove, IL in 2012 as an Assistant Professor in the Biomedical Sciences Program. She was promoted to Associate Professor with Tenure in 2017. In 2019, she became the Associate Program Director for the Precision Medicine Program in the College of Graduate Studies. Dr. Kristjansdottir was the President of the Chicago Mass Spectrometry Discussion Group (CMSDG) from 2016-2019 and is currently a member-at-large. Her current research interests include using proteomics and genomics to identify biomarkers for cancer progression and treatment efficacy, with a focus on breast cancer and neuroblastoma.

Associate Professor

Downers Grove, IL

College of Graduate Studies - IL
College of Graduate Studies - AZ

Biomedical Sciences

Biomedical Sciences (M.A.)
Biomedical Sciences (M.B.S.)

Call My


Send Me
a Message



Duke University | 2005 | Ph.D.
The University of Iceland | 1999 | M.S.
The University of Iceland | 1997 | B.S.

Courses Taught

Course Director
BISCD 0552, 0812             Fundamentals of Research
BISCD 0845, 0945            Biomarkers in Health and Disease
BIOCD 0510, 0560, 1554  Biochemistry I (Workshop facilitator)
BIOCD 0520, 0570, 1554  Biochemistry II (Workshop facilitator)
BISCD 0540, 0980             Pathophysiology
PTHED 1527                      Clinical Conditions I
BISCD 0856, 0958             Advanced Topics
BISCD 0558                       Literature Review
BISCD 0530, 0550             Professional Development


The long-term goal of our lab is to identify novel biomarkers. We use global genomic and mass spectrometry screens to identify potential targets. We then examine the role of the potential biomarkers using a wide range of functional assays.  Our lab is currently focused on Neuroblastoma, a pediatric cancer and breast cancer. Our results will help shed the light on the role of these proteins in cancer progression and potentially identify new biomarkers or drug targets for these cancers. The lab is also involved in a collaborative effort focused on enhancing and directing nerve regeneration after injury.



Chicago Mass Spectrometry Discussion Group (CMSDG)
Society for In Vitro Biology (SIVB)
The American Society for Biochemistry and Molecular Biology (ASBMB)